Target intelligence / Profile preview

Reactive electrophiles and oxidants (ROS/RES)

Target
ROS/RES
Molecular classification
Other, Reactive chemical species
01

Overview

Reactive electrophiles and oxidants are a diverse group of highly reactive chemical entities, including reactive oxygen species (ROS) and reactive nitrogen species (RNS), that play dual roles in biological systems. At physiological levels, they function as critical signaling molecules in processes such as vascular tone regulation and immune response; however, their overproduction leads to oxidative and electrophilic stress, causing irreversible damage to DNA, proteins, and lipids (Sies et al., 2017, Nature Reviews Molecular Cell Biology). This macromolecular damage is a hallmark of various pathologies, including cancer, neurodegeneration, and chronic inflammation (Forman & Zhang, 2021, Nature Reviews Drug Discovery). Pharmacological intervention typically involves the use of antioxidants to scavenge these species directly or the administration of Nrf2 activators to bolster the cell's natural defense mechanisms (Yamamoto et al., 2018, Physiological Reviews). Conversely, some therapeutic strategies, particularly in oncology, aim to exacerbate the levels of these reactive species to selectively trigger apoptosis in malignant cells. Because this term encompasses a broad range of chemical species rather than a specific protein or receptor, it is classified as a collective molecular category rather than a discrete therapeutic target.

Other names
Reactive oxygen speciesROSReactive nitrogen speciesRNSReactive electrophilic speciesRESFree radicalsOxidative stressorsElectrophilic metabolites
02

Mechanism of action

Direct chemical scavenging and neutralization of reactive species; induction of phase II detoxifying enzymes via activation of the Keap1-Nrf2-ARE signaling axis; inhibition of oxidant-producing enzymes such as NADPH oxidase (Sies et al., 2017, Nature Reviews Molecular Cell Biology).

03

Biological functions

Signal transductionCell deathImmune responseOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Interference with essential redox-dependent signaling pathwaysPotential to promote tumor survival in established cancersThe antioxidant paradox where supplementation fails to prevent or even exacerbates disease (Forman & Zhang, 2021, Nature Reviews Drug Discovery)
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)4-hydroxynonenal (4-HNE)Protein carbonylsReduced-to-oxidized glutathione (GSH/GSSG) ratio

Beyond the preview

Go deeper on Reactive electrophiles and oxidants (ROS/RES).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive electrophiles and oxidants (ROS/RES).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call